{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:02Z","timestamp":1791593822239,"version":"4.3.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s12026-014-8580-6","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T22:35:33Z","timestamp":1416004533000},"page":"320-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain\u2013Barr\u00e9 syndrome patients"],"prefix":"10.1007","volume":"60","author":[{"given":"Mohan S.","family":"Maddur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bolgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneger","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Magy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srini V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"issue":"10","key":"8580_CR1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med. 2001;345(10):747\u201355.","journal-title":"N Engl J Med"},{"issue":"11","key":"8580_CR2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","volume":"11","author":"SV Kaveri","year":"2012","unstructured":"Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev. 2012;11(11):792\u20134.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8580_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","volume":"7","author":"JF Seite","year":"2008","unstructured":"Seite JF, Shoenfeld Y, Youinou P, Hillion S. What is the contents of the magic draft IVIg? Autoimmun Rev. 2008;7(6):435\u20139.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8580_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrrheum.2011.61","volume":"7","author":"J Bayry","year":"2011","unstructured":"Bayry J, Negi VS, Kaveri SV. Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol. 2011;7(6):349\u201359.","journal-title":"Nat Rev Rheumatol"},{"issue":"19","key":"8580_CR5","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004;291(19):2367\u201375.","journal-title":"JAMA"},{"issue":"6","key":"8580_CR6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","volume":"7","author":"U Nussinovitch","year":"2008","unstructured":"Nussinovitch U, Shoenfeld Y. Intravenous immunoglobulin\u2014indications and mechanisms in cardiovascular diseases. Autoimmun Rev. 2008;7(6):445\u201352.","journal-title":"Autoimmun Rev"},{"issue":"21","key":"8580_CR7","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2012;367(21):2015\u201325.","journal-title":"N Engl J Med"},{"issue":"3","key":"8580_CR8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMcibr0803649","volume":"359","author":"SV Kaveri","year":"2008","unstructured":"Kaveri SV, Lacroix-Desmazes S, Bayry J. The antiinflammatory IgG. N Engl J Med. 2008;359(3):307\u20139.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"8580_CR9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","volume":"164","author":"SV Kaveri","year":"2011","unstructured":"Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol. 2011;164(Suppl 2):2\u20135.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8580_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2010.09.006","volume":"36","author":"J Bayry","year":"2011","unstructured":"Bayry J, Fournier EM, Maddur MS, Vani J, Wootla B, Siberil S, et al. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. J Autoimmun. 2011;36(1):9\u201315.","journal-title":"J Autoimmun"},{"issue":"39","key":"8580_CR11","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1073\/pnas.0402183101","volume":"101","author":"J Bayry","year":"2004","unstructured":"Bayry J, Lacroix-Desmazes S, Donkova-Petrini V, Carbonneil C, Misra N, Lepelletier Y, et al. Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci USA. 2004;101(39):14210\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"8580_CR12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.amjmed.2005.06.028","volume":"118","author":"J Bayry","year":"2005","unstructured":"Bayry J, Lacroix-Desmazes S, Hermine O, Oksenhendler E, Kazatchkine MD, Kaveri SV. Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin. Am J Med. 2005;118(12):1439\u201340.","journal-title":"Am J Med"},{"issue":"5","key":"8580_CR13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncprheum0481","volume":"3","author":"J Bayry","year":"2007","unstructured":"Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat Clin Pract Rheumatol. 2007;3(5):262\u201372.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6","key":"8580_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.autrev.2008.04.011","volume":"7","author":"J Vani","year":"2008","unstructured":"Vani J, Elluru S, Negi VS, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, et al. Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun Rev. 2008;7(6):440\u20134.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8580_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","volume":"27","author":"VS Negi","year":"2007","unstructured":"Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007;27(3):233\u201345.","journal-title":"J Clin Immunol"},{"issue":"12","key":"8580_CR16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","volume":"29","author":"T Tha-In","year":"2008","unstructured":"Tha-In T, Bayry J, Metselaar HJ, Kaveri SV, Kwekkeboom J. Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol. 2008;29(12):608\u201315.","journal-title":"Trends Immunol"},{"issue":"3","key":"8580_CR17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","volume":"13","author":"I Schwab","year":"2013","unstructured":"Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13(3):176\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"8580_CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","volume":"127","author":"M Ballow","year":"2011","unstructured":"Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol. 2011;127(2):315\u201323.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"8580_CR19","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/s10875-012-9842-5","volume":"33","author":"N Svetlicky","year":"2013","unstructured":"Svetlicky N, Ortega-Hernandez OD, Mouthon L, Guillevin L, Thiesen HJ, Altman A, et al. The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade. J Clin Immunol. 2013;33(Suppl 1):S27\u201332.","journal-title":"J Clin Immunol"},{"issue":"9497","key":"8580_CR20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain\u2013Barre syndrome. Lancet. 2005;366(9497):1653\u201366.","journal-title":"Lancet"},{"issue":"10","key":"8580_CR21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn van","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain\u2013Barre syndrome. Lancet Neurol. 2008;7(10):939\u201350.","journal-title":"Lancet Neurol"},{"issue":"4\u20135","key":"8580_CR22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.autrev.2014.01.033","volume":"13","author":"AH Eldar","year":"2014","unstructured":"Eldar AH, Chapman J. Guillain\u2013Barre syndrome and other immune mediated neuropathies: diagnosis and classification. Autoimmun Rev. 2014;13(4\u20135):525\u201330.","journal-title":"Autoimmun Rev"},{"key":"8580_CR23","doi-asserted-by":"crossref","unstructured":"Li S, Jin T, Zhang HL, Yu H, Meng F, Concha Quezada H et al. Circulating Th17, Th22, and Th1 Cells are elevated in the Guillain\u2013Barre syndrome and downregulated by IVIg treatments. Mediat Inflamm. 2014. doi: 10.1155\/2014\/740947 .","DOI":"10.1155\/2014\/740947"},{"issue":"2","key":"8580_CR24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cellimm.2011.08.015","volume":"271","author":"XL Li","year":"2011","unstructured":"Li XL, Dou YC, Liu Y, Shi CW, Cao LL, Zhang XQ, et al. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1\/Th17 cytokines and up-regulated T regulatory cells. Cell Immunol. 2011;271(2):455\u201361.","journal-title":"Cell Immunol"},{"issue":"5","key":"8580_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Zheng XY, Zhu J. Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013;24(5):443\u201353.","journal-title":"Cytokine Growth Factor Rev"},{"key":"8580_CR26","first-page":"260473","volume":"2012","author":"S Li","year":"2012","unstructured":"Li S, Yu M, Li H, Zhang H, Jiang Y. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain\u2013Barre syndrome. Mediat Inflamm. 2012;2012:260473.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"8580_CR27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol. 2009;9(6):393\u2013407.","journal-title":"Nat Rev Immunol"},{"key":"8580_CR28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"8580_CR29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK. Interleukin-17 and Type 17 helper T cells. N Engl J Med. 2009;361(9):888\u201398.","journal-title":"N Engl J Med"},{"issue":"1","key":"8580_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181(1):8\u201318.","journal-title":"Am J Pathol"},{"issue":"1\u20133","key":"8580_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12026-012-8364-9","volume":"55","author":"CL Roark","year":"2013","unstructured":"Roark CL, Huang Y, Jin N, Aydintug MK, Casper T, Sun D, et al. A canonical V\u03b34\u00a0V\u03b44+\u00a0\u03b3\u03b4 T cell population with distinct stimulation requirements which promotes the Th17 response. Immunol Res. 2013;55(1\u20133):217\u201330.","journal-title":"Immunol Res"},{"issue":"2","key":"8580_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/cmi.2012.72","volume":"10","author":"M Sharma","year":"2013","unstructured":"Sharma M, Kaveri SV, Bayry J. Th17 cells, pathogenic or not? TGF-\u03b23 imposes the embargo. Cell Mol Immunol. 2013;10(2):101\u20132.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8580_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12026-013-8481-0","volume":"58","author":"U Fiocco","year":"2014","unstructured":"Fiocco U, Accordi B, Martini V, Oliviero F, Facco M, Cabrelle A, et al. JAK\/STAT\/PKC\u03b4 molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunol Res. 2014;58(1):61\u20139.","journal-title":"Immunol Res"},{"issue":"1","key":"8580_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-013-8483-y","volume":"58","author":"Z Su","year":"2014","unstructured":"Su Z, Sun Y, Zhu H, Liu Y, Lin X, Shen H, et al. Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis. Immunol Res. 2014;58(1):118\u201324.","journal-title":"Immunol Res"},{"issue":"1","key":"8580_CR35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev. 2011;241(1):260\u20138.","journal-title":"Immunol Rev"},{"issue":"6","key":"8580_CR36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","volume":"13","author":"S Sakaguchi","year":"2013","unstructured":"Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nat Rev Immunol. 2013;13(6):461\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8580_CR37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrrheum.2012.149","volume":"9","author":"EJ Wehrens","year":"2013","unstructured":"Wehrens EJ, Prakken BJ, van Wijk F. T cells out of control\u2014impaired immune regulation in the inflamed joint. Nat Rev Rheumatol. 2013;9(1):34\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"8580_CR38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775\u201387.","journal-title":"Cell"},{"issue":"1","key":"8580_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","volume":"11","author":"K Wing","year":"2010","unstructured":"Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010;11(1):7\u201313.","journal-title":"Nat Immunol"},{"issue":"5","key":"8580_CR40","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2353\/ajpath.2009.080987","volume":"174","author":"S Andre","year":"2009","unstructured":"Andre S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol. 2009;174(5):1575\u201387.","journal-title":"Am J Pathol"},{"issue":"3","key":"8580_CR41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrrheum.2013.205","volume":"10","author":"T Kobezda","year":"2014","unstructured":"Kobezda T, Ghassemi-Nejad S, Mikecz K, Glant TT, Szekanecz Z. Of mice and men: how animal models advance our understanding of T-cell function in RA. Nat Rev Rheumatol. 2014;10(3):160\u201370.","journal-title":"Nat Rev Rheumatol"},{"issue":"2\u20133","key":"8580_CR42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12026-014-8512-5","volume":"58","author":"L Pellerin","year":"2014","unstructured":"Pellerin L, Jenks JA, Begin P, Bacchetta R, Nadeau KC. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res. 2014;58(2\u20133):358\u201368.","journal-title":"Immunol Res"},{"issue":"3","key":"8580_CR43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cmi.2013.2","volume":"10","author":"I Pedroza-Pacheco","year":"2013","unstructured":"Pedroza-Pacheco I, Madrigal A, Saudemont A. Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy. Cell Mol Immunol. 2013;10(3):222\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8580_CR44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12026-014-8488-1","volume":"60","author":"SJ Lin","year":"2014","unstructured":"Lin SJ, Lu CH, Yan DC, Lee PT, Hsiao HS, Kuo ML. Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25(+) T cells. Immunol Res. 2014;60(1):105\u201311.","journal-title":"Immunol Res"},{"issue":"9","key":"8580_CR45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","volume":"15","author":"J Harness","year":"2008","unstructured":"Harness J, McCombe PA. Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain\u2013Barre syndrome patients compared to controls. J Clin Neurosci. 2008;15(9):1031\u20135.","journal-title":"J Clin Neurosci"},{"issue":"1\u20132","key":"8580_CR46","first-page":"206","volume":"192","author":"LJ Chi","year":"2007","unstructured":"Chi LJ, Wang HB, Zhang Y, Wang WZ. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain\u2013Barre syndrome. J Neuroimmunol. 2007;192(1\u20132):206\u201314.","journal-title":"J Neuroimmunol"},{"key":"8580_CR47","first-page":"CD002063","volume":"7","author":"RA Hughes","year":"2012","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain\u2013Barre syndrome. Cochrane Database Syst Rev. 2012;7:CD002063.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"8580_CR48","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/s10875-010-9407-4","volume":"30","author":"PA Doorn van","year":"2010","unstructured":"van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG treatment and prognosis in Guillain\u2013Barre syndrome. J Clin Immunol. 2010;30(Suppl 1):S74\u20138.","journal-title":"J Clin Immunol"},{"issue":"4","key":"8580_CR49","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/cc10305","volume":"15","author":"MA El-Bayoumi","year":"2011","unstructured":"El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain\u2013Barre syndrome: a randomized study. Crit Care. 2011;15(4):R164.","journal-title":"Crit Care"},{"issue":"3","key":"8580_CR50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1385\/CRIAI:29:3:281","volume":"29","author":"M Harel","year":"2005","unstructured":"Harel M, Shoenfeld Y. Intravenous immunoglobulin and Guillain\u2013Barre syndrome. Clin Rev Allergy Immunol. 2005;29(3):281\u20137.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl 1","key":"8580_CR51","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s10875-010-9394-5","volume":"30","author":"MS Maddur","year":"2010","unstructured":"Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, Bayry J, et al. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol. 2010;30(Suppl 1):S4\u20138.","journal-title":"J Clin Immunol"},{"issue":"2","key":"8580_CR52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3899\/jrheum.111123","volume":"39","author":"J Bayry","year":"2012","unstructured":"Bayry J, Mouthon L, Kaveri SV. Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease. J Rheumatol. 2012;39(2):450\u20131.","journal-title":"J Rheumatol"},{"issue":"8","key":"8580_CR53","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","volume":"112","author":"AS Groot De","year":"2008","unstructured":"De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P, et al. Activation of natural regulatory T cells by IgG Fc-derived peptide \u201cTregitopes\u201d. Blood. 2008;112(8):3303\u201311.","journal-title":"Blood"},{"issue":"2","key":"8580_CR54","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood-2007-03-079947","volume":"111","author":"A Ephrem","year":"2008","unstructured":"Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, et al. Expansion of CD4+ CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 2008;111(2):715\u201322.","journal-title":"Blood"},{"issue":"8","key":"8580_CR55","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","volume":"179","author":"A Kessel","year":"2007","unstructured":"Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol. 2007;179(8):5571\u20135.","journal-title":"J Immunol"},{"issue":"6","key":"8580_CR56","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jaci.2012.02.050","volume":"129","author":"AH Massoud","year":"2012","unstructured":"Massoud AH, Guay J, Shalaby KH, Bjur E, Ablona A, Chan D, et al. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells. J Allergy Clin Immunol. 2012;129(6):1656\u201365 e3.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"8580_CR57","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaci.2013.09.029","volume":"133","author":"AH Massoud","year":"2014","unstructured":"Massoud AH, Yona M, Xue D, Chouiali F, Alturaihi H, Ablona A, et al. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J Allergy Clin Immunol. 2014;133(3):853\u201363 e5.","journal-title":"J Allergy Clin Immunol."},{"issue":"1 Suppl 57","key":"8580_CR58","first-page":"93","volume":"28","author":"B Olivito","year":"2010","unstructured":"Olivito B, Taddio A, Simonini G, Massai C, Ciullini S, Gambineri E, et al. Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. Clin Exp Rheumatol. 2010;28(1 Suppl 57):93\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"8580_CR59","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/TP.0b013e3181dd6bf1","volume":"89","author":"T Tha-In","year":"2010","unstructured":"Tha-In T, Metselaar HJ, Bushell AR, Kwekkeboom J, Wood KJ. Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+ Foxp3+ T cells. Transplantation. 2010;89(12):1446\u201355.","journal-title":"Transplantation"},{"issue":"5","key":"8580_CR60","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3899\/jrheum.110981","volume":"39","author":"N Tsurikisawa","year":"2012","unstructured":"Tsurikisawa N, Saito H, Oshikata C, Tsuburai T, Akiyama K. High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis. J Rheumatol. 2012;39(5):1019\u201325.","journal-title":"J Rheumatol"},{"issue":"8","key":"8580_CR61","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","volume":"122","author":"J Trinath","year":"2013","unstructured":"Trinath J, Hegde P, Sharma M, Maddur MS, Rabin M, Vallat JM, et al. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood. 2013;122(8):1419\u201327.","journal-title":"Blood"},{"issue":"2","key":"8580_CR62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cei.12102","volume":"173","author":"AS Tjon","year":"2013","unstructured":"Tjon AS, Tha-In T, Metselaar HJ, van Gent R, van der Laan LJ, Groothuismink ZM, et al. Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells. Clin Exp Immunol. 2013;173(2):259\u201367.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"8580_CR63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaci.2010.12.1102","volume":"127","author":"MS Maddur","year":"2011","unstructured":"Maddur MS, Vani J, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. J Allergy Clin Immunol. 2011;127(3):823\u201330 e1-7.","journal-title":"J Allergy Clin Immunol."},{"issue":"12","key":"8580_CR64","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2011.02.007","volume":"10","author":"MS Maddur","year":"2011","unstructured":"Maddur MS, Kaveri SV, Bayry J. Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmun Rev. 2011;10(12):809\u201310.","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"8580_CR65","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s10875-012-9752-6","volume":"33","author":"MS Maddur","year":"2013","unstructured":"Maddur MS, Sharma M, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J. Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations. J Clin Immunol. 2013;33(Suppl 1):S62\u20136.","journal-title":"J Clin Immunol"},{"issue":"9","key":"8580_CR66","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.1201965","volume":"190","author":"S Othy","year":"2013","unstructured":"Othy S, Hegde P, Topcu S, Sharma M, Maddur MS, Lacroix-Desmazes S, et al. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis. J Immunol. 2013;190(9):4535\u201341.","journal-title":"J Immunol"},{"issue":"7","key":"8580_CR67","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/eji.201444440","volume":"44","author":"S Othy","year":"2014","unstructured":"Othy S, Topcu S, Saha C, Kothapalli P, Lacroix-Desmazes S, Kasermann F, et al. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin. Eur J Immunol. 2014;44(7):2059\u201363.","journal-title":"Eur J Immunol"},{"issue":"11","key":"8580_CR68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni.1939","volume":"11","author":"G Liu","year":"2010","unstructured":"Liu G, Yang K, Burns S, Shrestha S, Chi H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol. 2010;11(11):1047\u201356.","journal-title":"Nat Immunol"},{"issue":"Suppl","key":"8580_CR69","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain\u2013Barre syndrome. Ann Neurol. 1990;27(Suppl):S21\u20134.","journal-title":"Ann Neurol"},{"issue":"5","key":"8580_CR70","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","volume":"72","author":"IS Merkies","year":"2002","unstructured":"Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2002;72(5):596\u2013601.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"8580_CR71","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","volume":"77","author":"RC Graham","year":"2006","unstructured":"Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006;77(8):973\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"8580_CR72","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","volume":"38","author":"N Ohkura","year":"2013","unstructured":"Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38(3):414\u201323.","journal-title":"Immunity"},{"issue":"13\u201314","key":"8580_CR73","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.drudis.2007.05.002","volume":"12","author":"J Bayry","year":"2007","unstructured":"Bayry J, Siberil S, Triebel F, Tough DF, Kaveri SV. Rescuing CD4+ CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy. Drug Discov Today. 2007;12(13\u201314):548\u201352.","journal-title":"Drug Discov Today"},{"key":"8580_CR74","doi-asserted-by":"crossref","unstructured":"Maddur MS, Trinath J, Rabin M, Vallat JM, Magy L, Balaji KN et al. Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with an increased prostaglandin E2 in the circulation. Cell Mol Immunol (in press).","DOI":"10.1038\/cmi.2014.117"},{"key":"8580_CR75","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/ncomms5092","volume":"5","author":"MS Maddur","year":"2014","unstructured":"Maddur MS, Sharma M, Hegde P, Stephen-Victor E, Pulendran B, Kaveri SV, et al. Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand. Nat Commun. 2014;5:4092. doi: 10.1038\/ncomms5092 .","journal-title":"Nat Commun"},{"issue":"1","key":"8580_CR76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","volume":"162","author":"S Jia","year":"2010","unstructured":"Jia S, Li C, Wang G, Yang J, Zu Y. The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol. 2010;162(1):131\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8580_CR77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/aji.12208","volume":"71","author":"DJ Kim","year":"2014","unstructured":"Kim DJ, Lee SK, Kim JY, Na BJ, Hur SE, Lee M, et al. Intravenous immunoglobulin g modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss. Am J Reprod Immunol. 2014;71(5):441\u201350.","journal-title":"Am J Reprod Immunol"},{"issue":"7","key":"8580_CR78","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/art.38627","volume":"66","author":"SY Lee","year":"2014","unstructured":"Lee SY, Jung YO, Ryu JG, Kang CM, Kim EK, Son HJ, et al. Intravenous immunoglobulin attenuates experimental autoimmune arthritis by inducing reciprocal regulation of th17 and treg cells in an interleukin-10-dependent manner. Arthritis Rheumatol. 2014;66(7):1768\u201378.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"8580_CR79","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","volume":"101","author":"J Bayry","year":"2003","unstructured":"Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 2003;101(2):758\u201365.","journal-title":"Blood"},{"issue":"12","key":"8580_CR80","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/art.11346","volume":"48","author":"J Bayry","year":"2003","unstructured":"Bayry J, Lacroix-Desmazes S, Delignat S, Mouthon L, Weill B, Kazatchkine MD, et al. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus. Arthritis Rheum. 2003;48(12):3497\u2013502.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8580_CR81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.175.1.15","volume":"175","author":"J Bayry","year":"2005","unstructured":"Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol. 2005;175(1):15\u201320.","journal-title":"J Immunol"},{"issue":"9","key":"8580_CR82","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2009-06-225417","volume":"115","author":"E Aubin","year":"2010","unstructured":"Aubin E, Lemieux R, Bazin R. Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation. Blood. 2010;115(9):1727\u201334.","journal-title":"Blood"},{"issue":"3","key":"8580_CR83","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaut.2012.05.013","volume":"39","author":"S Othy","year":"2012","unstructured":"Othy S, Bruneval P, Topcu S, Dugail I, Delers F, Lacroix-Desmazes S, et al. Effect of IVIg on human dendritic cell-mediated antigen uptake and presentation: role of lipid accumulation. J Autoimmun. 2012;39(3):168\u201372.","journal-title":"J Autoimmun"},{"issue":"10","key":"8580_CR84","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/art.38082","volume":"65","author":"AE Wiedeman","year":"2013","unstructured":"Wiedeman AE, Santer DM, Yan W, Miescher S, Kasermann F, Elkon KB. Contrasting mechanisms of interferon-alpha inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists. Arthritis Rheum. 2013;65(10):2713\u201323.","journal-title":"Arthritis Rheum"},{"issue":"7161","key":"8580_CR85","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419\u201326.","journal-title":"Nature"},{"issue":"8","key":"8580_CR86","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nri3477","volume":"13","author":"D Ganguly","year":"2013","unstructured":"Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013;13(8):566\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"8580_CR87","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2011-09-379776","volume":"120","author":"C Vitali","year":"2012","unstructured":"Vitali C, Mingozzi F, Broggi A, Barresi S, Zolezzi F, Bayry J, et al. Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood. 2012;120(6):1237\u201345.","journal-title":"Blood"},{"issue":"4","key":"8580_CR88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaci.2013.01.031","volume":"131","author":"J Trinath","year":"2013","unstructured":"Trinath J, Hegde P, Balaji KN, Kaveri SV, Bayry J. Intravenous immunoglobulin-mediated regulation of Notch ligands on human dendritic cells. J Allergy Clin Immunol. 2013;131(4):1255\u20137 7 e1.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"8580_CR89","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","volume":"12","author":"LP Cousens","year":"2013","unstructured":"Cousens LP, Tassone R, Mazer BD, Ramachandiran V, Scott DW, De Groot AS. Tregitope update: mechanism of action parallels IVIg. Autoimmun Rev. 2013;12(3):436\u201343.","journal-title":"Autoimmun Rev"},{"issue":"7354","key":"8580_CR90","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","volume":"475","author":"RM Anthony","year":"2011","unstructured":"Anthony RM, Kobayashi T, Wermeling F, Ravetch JV. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 2011;475(7354):110\u20133.","journal-title":"Nature"},{"issue":"9","key":"8580_CR91","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1073\/pnas.0900016106","volume":"106","author":"J Bayry","year":"2009","unstructured":"Bayry J, Bansal K, Kazatchkine MD, Kaveri SV. DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells. Proc Natl Acad Sci USA. 2009;106(9):E24.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"22","key":"8580_CR92","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1182\/blood-2012-03-415695","volume":"119","author":"D Leontyev","year":"2012","unstructured":"Leontyev D, Katsman Y, Branch DR. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcgamma receptor for the amelioration of experimental ITP. Blood. 2012;119(22):5261\u20134.","journal-title":"Blood"},{"key":"8580_CR93","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1038\/srep05672","volume":"4","author":"M Sharma","year":"2014","unstructured":"Sharma M, Schoindre Y, Hegde P, Saha C, Maddur MS, Stephen-Victor E, et al. Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients. Sci Rep. 2014;4:5672. doi: 10.1038\/srep05672 .","journal-title":"Sci Rep"},{"issue":"11","key":"8580_CR94","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.4049\/jimmunol.1301611","volume":"192","author":"IK Campbell","year":"2014","unstructured":"Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, et al. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J Immunol. 2014;192(11):5031\u20138.","journal-title":"J Immunol."},{"key":"8580_CR95","doi-asserted-by":"crossref","unstructured":"Bayry J, Lacroix-Desmazes S, Dasgupta S, Kazatchkine MD, Kaveri SV. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants? Nat Rev Immunol. 2008;8(1). doi: 10.1038\/nri2138-c1 .","DOI":"10.1038\/nri2138-c1"},{"issue":"2","key":"8580_CR96","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2011.08.004","volume":"11","author":"MS Maddur","year":"2011","unstructured":"Maddur MS, Hegde P, Sharma M, Kaveri SV, Bayry J. B cells are resistant to immunomodulation by \u2018IVIg-educated\u2019 dendritic cells. Autoimmun Rev. 2011;11(2):154\u20136.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8580_CR97","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","volume":"116","author":"JF Seite","year":"2010","unstructured":"Seite JF, Cornec D, Renaudineau Y, Youinou P, Mageed RA, Hillion S. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood. 2010;116(10):1698\u2013704.","journal-title":"Blood"},{"issue":"1","key":"8580_CR98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2013.08.042","volume":"133","author":"JF Seite","year":"2014","unstructured":"Seite JF, Goutsmedt C, Youinou P, Pers JO, Hillion S. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. J Allergy Clin Immunol. 2014;133(1):181\u20138 e1-9.","journal-title":"J Allergy Clin Immunol"},{"issue":"1\u20132","key":"8580_CR99","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2011.08.005","volume":"238","author":"K Moriguchi","year":"2011","unstructured":"Moriguchi K, Miyamoto K, Takada K, Kusunoki S. Four cases of anti-ganglioside antibody-positive neuralgic amyotrophy with good response to intravenous immunoglobulin infusion therapy. J Neuroimmunol. 2011;238(1\u20132):107\u20139.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"8580_CR100","doi-asserted-by":"crossref","first-page":"e26469","DOI":"10.1371\/journal.pone.0026469","volume":"6","author":"S Casulli","year":"2011","unstructured":"Casulli S, Topcu S, Fattoum L, von Gunten S, Simon HU, Teillaud JL, et al. A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms. PLoS One. 2011;6(10):e26469.","journal-title":"PLoS One"},{"issue":"2","key":"8580_CR101","doi-asserted-by":"crossref","first-page":"e31357","DOI":"10.1371\/journal.pone.0031357","volume":"7","author":"JW Semple","year":"2012","unstructured":"Semple JW, Kim M, Hou J, McVey M, Lee YJ, Tabuchi A, et al. Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production. PLoS One. 2012;7(2):e31357.","journal-title":"PLoS One"},{"issue":"5","key":"8580_CR102","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri3401-c1","volume":"14","author":"S Gunten von","year":"2014","unstructured":"von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, Kasermann F, et al. IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol. 2014;14(5):349.","journal-title":"Nat Rev Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-014-8580-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8580-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T01:47:41Z","timestamp":1717552061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-014-8580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":102,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["8580"],"URL":"https:\/\/doi.org\/10.1007\/s12026-014-8580-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}